Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 30, 2024Frontiers in ImmunologyOpen Access

Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHenry SmithKagoshima UniversityEAEdward Arbe-BarnesJohn Radcliffe HospitalEAEnas Abu‐ShahNuffield Orthopaedic Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Smith et al. (2024) studied this question.

synapsesocial.com/papers/68e67a85b6db643587603fe5https://doi.org/10.3389/fimmu.2024.1406250
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma2010 · 1,281 citations
  2. 2CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.1995 · 2,255 citations
  3. 3High expression of CD73 as a poor prognostic biomarker in human colorectal cancer2012 · 179 citations